Antibody Fragments Functionalized with Non-canonical Amino Acids Preserving Structure and Functionality - A Door Opener for New Biological and Therapeutic Applications
Overview
Authors
Affiliations
Functionalization of proteins by incorporating reactive non-canonical amino acids (ncAAs) has been widely applied for numerous biological and therapeutic applications. The requirement not to lose the intrinsic properties of these proteins is often underestimated and not considered. Main purpose of this study was to answer the question whether functionalization via residue-specific incorporation of the ncAA N-[(2-Azidoethoxy) carbonyl]-l-lysine (Azk) influences the properties of the anti-tumor-necrosis-factor-α-Fab (FTN2). Therefore, FTN2 variants with different Azk incorporation sites were designed and amber codon suppression was used for production. The functionalized FTN2 variants were efficiently produced in fed-batch like μ-bioreactor cultivations in the periplasm of displaying correct structure and antigen binding affinities comparable to those of wild-type FTN2. Our FTN2 variants with reactive handles for diverse conjugates enable tracking of recombinant protein in the production cell, pharmacological studies and translation into new pharmaceutical applications.
Hanaee-Ahvaz H, Baumann M, Tauer C, Albrecht B, Wiltschi B, Cserjan-Puschmann M Sci Rep. 2024; 14(1):25375.
PMID: 39455661 PMC: 11511901. DOI: 10.1038/s41598-024-73162-9.
Can antibodies be "vegan"? A guide through the maze of today's antibody generation methods.
Dubel S MAbs. 2024; 16(1):2343499.
PMID: 38634488 PMC: 11028021. DOI: 10.1080/19420862.2024.2343499.